BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

395 related articles for article (PubMed ID: 28964660)

  • 1. Prediction of lymph node metastasis in pancreatic neuroendocrine tumors by contrast enhancement characteristics.
    Mizumoto T; Toyama H; Terai S; Mukubou H; Yamashita H; Shirakawa S; Nanno Y; Sofue K; Kido M; Ajiki T; Fukumoto T
    Pancreatology; 2017; 17(6):956-961. PubMed ID: 28964660
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pancreatic neuroendocrine tumors containing areas of iso- or hypoattenuation in dynamic contrast-enhanced computed tomography: Spectrum of imaging findings and pathological grading.
    Hyodo R; Suzuki K; Ogawa H; Komada T; Naganawa S
    Eur J Radiol; 2015 Nov; 84(11):2103-9. PubMed ID: 26321494
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differentiation of hypovascular pancreatic neuroendocrine tumors from pancreatic ductal adenocarcinoma using contrast-enhanced computed tomography.
    Ren S; Chen X; Wang Z; Zhao R; Wang J; Cui W; Wang Z
    PLoS One; 2019; 14(2):e0211566. PubMed ID: 30707733
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pancreatic neuroendocrine tumors: MR imaging features preoperatively predict lymph node metastasis.
    Sun H; Zhou J; Liu K; Shen T; Wang X; Wang X
    Abdom Radiol (NY); 2019 Mar; 44(3):1000-1009. PubMed ID: 30539251
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The prognostic value of multidetector CT features in predicting overall survival outcomes in patients with pancreatic neuroendocrine tumors.
    Yang B; Chen HY; Zhang XY; Pan Y; Lu YF; Yu RS
    Eur J Radiol; 2020 Mar; 124():108847. PubMed ID: 31991300
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regional lymphadenectomy is indicated in the surgical treatment of pancreatic neuroendocrine tumors (PNETs).
    Hashim YM; Trinkaus KM; Linehan DC; Strasberg SS; Fields RC; Cao D; Hawkins WG
    Ann Surg; 2014 Feb; 259(2):197-203. PubMed ID: 24253141
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analysis of lymph node metastasis in pancreatic neuroendocrine tumors (PNETs) based on the tumor size and hormonal production.
    Tsutsumi K; Ohtsuka T; Mori Y; Fujino M; Yasui T; Aishima S; Takahata S; Nakamura M; Ito T; Tanaka M
    J Gastroenterol; 2012 Jun; 47(6):678-85. PubMed ID: 22350698
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lymph node sampling rates and predictors of nodal metastasis in pancreatic neuroendocrine tumor resections: the UCSF experience with 149 patients.
    Parekh JR; Wang SC; Bergsland EK; Venook AP; Warren RS; Kim GE; Nakakura EK
    Pancreas; 2012 Aug; 41(6):840-4. PubMed ID: 22781907
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nonhypervascular pancreatic neuroendocrine tumors: Spectrum of MDCT imaging findings and differentiation from pancreatic ductal adenocarcinoma.
    Karmazanovsky G; Belousova E; Schima W; Glotov A; Kalinin D; Kriger A
    Eur J Radiol; 2019 Jan; 110():66-73. PubMed ID: 30599875
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Significance of lymph node metastasis in pancreatic neuroendocrine tumor.
    Taki K; Hashimoto D; Nakagawa S; Ozaki N; Tomiyasu S; Ohmuraya M; Arima K; Kaida T; Higashi T; Sakamoto K; Sakata K; Okabe H; Nitta H; Hayashi H; Chikamoto A; Beppu T; Takamori H; Hirota M; Baba H
    Surg Today; 2017 Sep; 47(9):1104-1110. PubMed ID: 28229300
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pancreatic neuroendocrine tumors: radiographic calcifications correlate with grade and metastasis.
    Poultsides GA; Huang LC; Chen Y; Visser BC; Pai RK; Jeffrey RB; Park WG; Chen AM; Kunz PL; Fisher GA; Norton JA
    Ann Surg Oncol; 2012 Jul; 19(7):2295-303. PubMed ID: 22396008
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nonhypervascular Pancreatic Neuroendocrine Tumors: Differential Diagnosis from Pancreatic Ductal Adenocarcinomas at MR Imaging-Retrospective Cross-sectional Study.
    Jeon SK; Lee JM; Joo I; Lee ES; Park HJ; Jang JY; Ryu JK; Lee KB; Han JK
    Radiology; 2017 Jul; 284(1):77-87. PubMed ID: 28092495
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Textural analysis on contrast-enhanced CT in pancreatic neuroendocrine neoplasms: association with WHO grade.
    Guo C; Zhuge X; Wang Z; Wang Q; Sun K; Feng Z; Chen X
    Abdom Radiol (NY); 2019 Feb; 44(2):576-585. PubMed ID: 30182253
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Contrast-Enhanced Ultrasonography Findings Correlate with Pathologic Grades of Pancreatic Neuroendocrine Tumors.
    Huang J; Chen J; Xu M; Zheng Y; Lin M; Huang G; Xie X; Xie X
    Ultrasound Med Biol; 2021 Aug; 47(8):2097-2106. PubMed ID: 33934943
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Solid non-functioning endocrine tumors of the pancreas: correlating computed tomography and pathology.
    Zamboni GA; Ambrosetti MC; Zivelonghi C; Lombardo F; Butturini G; Cingarlini S; Capelli P; Pozzi Mucelli R
    HPB (Oxford); 2017 Nov; 19(11):986-991. PubMed ID: 28784262
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regional Metastatic Behavior of Nonfunctional Pancreatic Neuroendocrine Tumors: Impact of Lymph Node Positivity on Survival.
    Jutric Z; Grendar J; Hoen HM; Cho SW; Cassera MA; Newell PH; Hammill CW; Hansen PD; Wolf RF
    Pancreas; 2017 Aug; 46(7):898-903. PubMed ID: 28697130
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differentiation of intrapancreatic accessory spleen from small hypervascular neuroendocrine tumor of the pancreas: textural analysis on contrast-enhanced computed tomography.
    Lin X; Xu L; Wu A; Guo C; Chen X; Wang Z
    Acta Radiol; 2019 May; 60(5):553-560. PubMed ID: 30086651
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinicopathological features of small nonfunctioning pancreatic neuroendocrine tumors.
    Furukori M; Imai K; Karasaki H; Watanabe K; Oikawa K; Miyokawa N; Taniguchi M; Furukawa H
    World J Gastroenterol; 2014 Dec; 20(47):17949-54. PubMed ID: 25548493
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quantitative analysis of enhanced CT in differentiating well-differentiated pancreatic neuroendocrine tumors and poorly differentiated neuroendocrine carcinomas.
    Chen HY; Pan Y; Chen JY; Liu LL; Yang YB; Li K; Yu RS; Shao GL
    Eur Radiol; 2022 Dec; 32(12):8317-8325. PubMed ID: 35759016
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Contrast-enhanced MDCT in patients with pancreatic neuroendocrine tumours: correlation with histological findings and diagnostic performance in differentiation between tumour grades.
    Belousova E; Karmazanovsky G; Kriger A; Kalinin D; Mannelli L; Glotov A; Karelskaya N; Paklina O; Kaldarov A
    Clin Radiol; 2017 Feb; 72(2):150-158. PubMed ID: 27890421
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.